Fighting Back Against Immunosuppressive Disorders.
The Division of Rheumatology and Clinical Immunology continues to be a worldwide leader both clinically and academically, and on the leading edge of research that ultimately offers patients the latest clinical therapies. UPMC has been named one of the top programs for rheumatology in the United States by U.S. News & World Report
every year since 2007. The division includes physicians and faculty members who are included among the peer-selected Best Doctors in America.
Among this year's highlights are:
- innovative clinical and laboratory research programs
- unique opportunities for future academic rheumatologists
- extramural funding to investigate:
- tissue pathogenesis
- systemic lupus erythematosus
- rheumatoid arthritis
- systemic sclerosis
- other significant clinical issues
We are committed to a mission of providing the highest quality care for patients with arthritis and autoimmune diseases, and mentoring and training medical students, residents, fellows, and young faculty. Our research mission is to better understand arthritis, autoimmune, and other connective tissue diseases in order to improve diagnosis and therapies, with the ultimate goal of finding ways to cure and prevent these disorders.
I invite you to view our online annual report and thank you for visiting.
Larry Moreland, MD
Division Chief and Professor
Margaret Jane Miller Endowed Professorship for Arthritis Research